General Information of This Metabolic Reaction (MR) (ID: MR007291)
Formula Reactant BAY-1002670 Product BAY-1002670 M19
Reactant Info Product Info
Metabolic Enzyme Succinic semialdehyde reductase (AKR7A2) DME Info
Cytochrome P450 3A4 (CYP3A4) DME Info
Metabolic Type Oxidation - Oxidationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007292 BAY-1002670 BAY-1002670 M1 Conjugation - Glucuronidation BAY-1002670 [1]
MR007290 BAY-1002670 BAY-1002670 M12 Multi-steps Reaction - Reduction; oxidation BAY-1002670 [1]
MR007293 BAY-1002670 BAY-1002670 M20 Unclear BAY-1002670 [1]
MR007286 BAY-1002670 BAY-1002670 M4 Reduction - Reduction BAY-1002670 [1]
MR007289 BAY-1002670 BAY-1002670 M7 Multi-steps Reaction - Reduction; oxidation BAY-1002670 [1]
References
1 Characterization of the pharmacokinetics of vilaprisan: bioavailability, excretion, biotransformation, and drug-drug interaction potential. Clin Pharmacokinet. 2018 Aug;57(8):1001-1015.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.